| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000267747.1 |
Bosutinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.003651852 |
Resistant |
| ENSG00000267747.1 |
Bosutinib |
Multiple myeloma plasma cell leukemia |
0.036336686 |
Resistant |
| ENSG00000267747.1 |
Bosutinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001909747 |
Resistant |
